|
ABCC5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.95310000026406E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.823100E-04 |
| Normal-vs-Stage2 |
3.46380000004753E-06 |
| Normal-vs-Stage3 |
3.93099999995705E-07 |
| Normal-vs-Stage4 |
3.52500000000422E-05 |
| Stage1-vs-Stage2 |
8.802500E-02 |
| Stage1-vs-Stage3 |
2.450200E-02 |
| Stage1-vs-Stage4 |
1.142180E-01 |
| Stage2-vs-Stage3 |
7.974200E-01 |
| Stage2-vs-Stage4 |
9.366400E-01 |
| Stage3-vs-Stage4 |
8.729000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.45089999999504E-05 |
| Normal-vs-AfricanAmerican |
2.366000E-04 |
| Normal-vs-Asian |
1.129510E-02 |
| Caucasian-vs-AfricanAmerican |
3.678000E-01 |
| Caucasian-vs-Asian |
4.836400E-01 |
| AfricanAmerican-vs-Asian |
1.596580E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.450000E-04 |
| Normal-vs-Female |
8.0096999999224E-07 |
| Male-vs-Female |
5.817200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.87659999999679E-05 |
| Normal-vs-Age(41-60Yrs) |
7.64819999999888E-05 |
| Normal-vs-Age(61-80Yrs) |
1.66568999999672E-05 |
| Normal-vs-Age(81-100Yrs) |
1.313370E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.881400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.328600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.066400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.873400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.499800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.902600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.137520E-02 |
| Classical-VS-Follicular |
2.638700E-04 |
| Classical-VS-Other |
6.548000E-01 |
| Classical-VS-Normal |
3.394500E-04 |
| Tall-VS-Follicular |
9.458800E-01 |
| Tall-VS-Other |
3.981400E-01 |
| Tall-VS-Normal |
2.0241999999504E-06 |
| Follicular-VS-Other |
3.887800E-01 |
| Follicular-VS-Normal |
7.55469997670843E-09 |
| Other-VS-Normal |
9.687400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.64410999999864E-05 |
| Normal-vs-N1 |
1.811460E-04 |
| N0-vs-N1 |
7.783400E-01 |
|
|
